A. Palenko

Early lipid profile deterioration during chemotherapy as a marker of subclinical vascular toxicity and therapy rationale

In patients with low and moderate baseline CV risk, a statistically significant deterioration in lipid profile was observed during chemotherapy, which is consistent with the development of subclinical endothelial dysfunction and early vascular toxicity, despite the absence of overt clinical manifestations of vasculotox...